IMBiologics

Q: What is IMBiologics's official website?

IMBiologics's official website is www.imbiologics.com

Q: What is IMBiologics's Revenue?

IMBiologics's revenue is <$5 Million

Q: How many employees does IMBiologics have?

IMBiologics has 11-50 employees

Q: What industry does IMBiologics belong to?

IMBiologics is in the industry of: Business Services , Research & Development

Q: What does IMBiologics do?

IMBiologics is an innovative biopharmaceutical company established in August 2020, specializing in the development of antibody-based therapeutics for autoimmune diseases and immuno-oncology. Utilizing their proprietary antibody modality technology, IM-OpDECon, the company aims to address unmet medical needs in the field of immunomodulatory biologic... s. With a vision to launch global blockbuster drugs, IMBiologics aspires to become a leading biotech firm capable of developing and obtaining approvals for innovative medicines. The company is focused on expanding its pipeline through advanced antibody design and optimization techniques. Read More

Q: Is IMBiologics a public company?

IMBiologics is private company therefore does not currently have an official ticker symbol

Business Services · South Korea · 11-50 Employees

View Company Info for Free

Overview

Headquarters

광교 센트럴비 260 즈타워 11층, 수원시, 경기도, South Kor...

Website

www.imbiologics.com

Revenue

<$5 Million

Industry

Business Services

Research & Development

ZI Rank: 1

Signal Type

Mar

Apr

May

Jun

Jul

Aug

ZI Rank

About IMBiologics

IMBiologics is an innovative biopharmaceutical company established in August 2020, specializing in the development of antibody-based therapeutics for autoimmune diseases and immuno-oncology. Utilizing their proprietary antibody modality technology, IM-OpDECon, the company aims to address unmet medical needs in the field of immunomodulatory biologics. With a vision to launch global blockbuster drugs, IMBiologics aspires to become a leading biotech firm capable of developing and obtaining approvals for innovative medicines. The company is focused on expanding its pipeline through advanced antibody design and optimization techniques.Explore more

Is this data correct?

View contact profiles from IMBiologics

Popular SearchesIMBiologics CorpSIC Code 87,873NAICS Code 54,541Show more

IMBiologics Org Chart

GyongSik Ha

Chief Executive Officer

Phone

Chihye Park

Cdo & Department Head of Development

Phone

Get the full picture

Jinwook Kim

Business Development Manager

Phone

Get the full picture

Is IMBiologics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Check if IMBiologics has recently received funding, and reach out quickly before it becomes old news!

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Click to see if IMBiologics had a recent Job posting/layoffs

Congratulate Masked Content for being promoted to Masked Content at IMBiologics

IMBiologics, which may be a good buyer, showed buying intent in Masked Content Topic

Funding: Get notified immidiatlly once IMBiologics has new funding data

Website visits: Recent activity has been detected on your website

Earning: See what the market has to say on IMBiologics recently announced quarterly report

Check out if IMBiologics is spiking on competitors!

Product Launch: Get notified when IMBiologics launches new products

Recommended Actions

Find VP level buyers at IMBiologics

Find more new buyers

View Email Formats for IMBiologics

Among all Business Services companies

Low Activity

High Activity

Activity Insights

IMBiologics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

IMBiologics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about IMBiologics.